| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |